Evidence map›Paper›PMID 35082143›Full record

ArticleRNA (New York, N.Y.)2022

Alternative splicing regulation of membrane trafficking genes during myogenesis.

Emma R Hinkle, Hannah J Wiedner, Eduardo V Torres, Micaela Jackson, Adam J Black, R Eric Blue, Sarah E Harris, Bryan B Guzman, Gabrielle M Gentile, Eunice Y Lee and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in RNA (New York, N.Y.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Understanding species-specific and conserved RNA-protein interactionsbioRxiv : the preprint server for biology · 2024
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Emma R Hinkle *Department of Cell Biology and Physiology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.ORCID 0000-0002-7396-7525
Hannah J Wiedner *Department of Cell Biology and Physiology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.ORCID 0000-0002-5919-5944
Eduardo V TorresDepartment of Cell Biology and Physiology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.ORCID 0000-0002-1951-7320
Micaela JacksonDepartment of Cell Biology and Physiology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.
Adam J BlackDepartment of Cell Biology and Physiology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.ORCID 0000-0002-5205-3513
R Eric BlueDepartment of Cell Biology and Physiology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.ORCID 0000-0002-9774-6778
Sarah E HarrisDepartment of Biochemistry and Biophysics, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.
Bryan B GuzmanDepartment of Pharmacology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.
Gabrielle M GentileDepartment of Cell Biology and Physiology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.ORCID 0000-0002-2669-1861
Eunice Y LeeDepartment of Cell Biology and Physiology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.
Yi-Hsuan TsaiLineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.
Joel ParkerCurriculum in Genetics and Molecular Biology (GMB), The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.
Daniel DominguezDepartment of Pharmacology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.
Jimena GiudiceDepartment of Cell Biology and Physiology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.ORCID 0000-0002-3330-7784
University of North Carolina at Chapel Hill · US

Funding

UNC Initiative for Maximizing Student DevelopmentR25GM055336 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI COOK, JEANETTE GOWEN, KASH, THOMAS L. · 1996 to 2023
$12.1M
NRSA IN GENETICST32GM007092 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SEKELSKY, JEFF J. · 1985 to 2019
$5.9M
MOLECULAR AND CELLULAR BIOPHYSICS TRAINING PROGRAMT32GM008570 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KUHLMAN, BRIAN A, SLEP, KEVIN C · 1995 to 2022
$5.1M
Predoctoral Training in the Pharmacological SciencesT32GM135095 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Joseph Mauro Calabrese, Michael James Emanuele · 2020 to 2026
$3.6M
Equipment -NEON transfection equipmentR01GM130866 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI GIUDICE, JIMENA · 2019 to 2023
$1.6M
Training in Mechanistic, Interdisciplinary Studies of Biological SystemsT32GM119999 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RAMSDEN, DALE A · 2017 to 2021
$1.2M
Alternative splicing regulation and glucose metabolism in the heartF32HL149147 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BLACK, ADAM J · 2019 to 2021
$181k
Alternative Splicing Regulation and Mechanotransduction in Skeletal MuscleF31AR077381 · NIAMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HINKLE, EMMA · 2021 to 2022
$66k
NHLBI NIH HHS F32 HL149147NIAMS NIH HHS F31 AR077381NIGMS NIH HHS R01 GM130866NIGMS NIH HHS R25 GM055336NIGMS NIH HHS T32 GM007092NIGMS NIH HHS T32 GM008570NIGMS NIH HHS T32 GM119999NIGMS NIH HHS T32 GM135095
6 · The paper itself

Abstract

Alternative splicing transitions occur during organ development, and, in numerous diseases, splicing programs revert to fetal isoform expression. We previously found that extensive splicing changes occur during postnatal mouse heart development in genes encoding proteins involved in vesicle-mediated trafficking. However, the regulatory mechanisms of this splicing-trafficking network are unknown. Here, we found that membrane trafficking genes are alternatively spliced in a tissue-specific manner, with striated muscles exhibiting the highest levels of alternative exon inclusion. Treatment of differentiated muscle cells with chromatin-modifying drugs altered exon inclusion in muscle cells. Examination of several RNA-binding proteins revealed that the poly-pyrimidine tract binding protein 1 (PTBP1) and quaking regulate splicing of trafficking genes during myogenesis, and that removal of PTBP1 motifs prevented PTBP1 from binding its RNA target. These findings enhance our understanding of developmental splicing regulation of membrane trafficking proteins which might have implications for muscle disease pathogenesis.

Indexed as

Alternative SplicingPolypyrimidine Tract-Binding ProteinAnimalsExonsHeterogeneous-Nuclear RibonucleoproteinsMiceMuscle DevelopmentHeterogeneous-Nuclear RibonucleoproteinsPolypyrimidine Tract-Binding Proteinalternative splicingmembrane traffickingmyogenesisRNA-binding proteins

Identifiers

PMID35082143
PMCPMC8925968
OpenAlexW4210699973

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.